Cargando…

Adjuvant interferon in the treatment of melanoma – reply

Detalles Bibliográficos
Autor principal:	Middleton, M R
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374524/ http://dx.doi.org/10.1054/bjoc.1999.1244

Ejemplares similares

Adjuvant interferon in the treatment of melanoma
por: Kirkwood, J M
Publicado: (2000)

Adjuvant interferon in the treatment of melanoma
por: Middleton, M R
Publicado: (1999)

Adjuvant interferon in melanoma – a resurrection?
por: Middleton, M R, et al.
Publicado: (2001)

Reply to Jakovac: COVID-19, vitamin D, and type I interferon
por: Gauzzi, Maria Cristina, et al.
Publicado: (2020)

Reply: Value of tyrosinase RT–PCR in melanoma prognosis
por: Gogas, H
Publicado: (2003)

Reply: KRAS mutation in colorectal cancer metastases after adjuvant folfox for the primary
por: Yoshino, T, et al.
Publicado: (2012)

Reply to Dorgham et al., “Considering Personalized Interferon Beta Therapy for COVID-19”
por: Davoudi-Monfared, Effat, et al.
Publicado: (2021)

Reply to: The diagnostic accuracy of (18)F-FDG PET in cutaneous malignant melanoma
por: Delgado-Bolton, Roberto C., et al.
Publicado: (2010)

Reply to comment on: strong reduction of AGO2 expression in melanoma and cellular consequences
por: Völler, D, et al.
Publicado: (2014)

Reply: Adjuvant chemoradiotherapy is no alternative to intensified neoadjuvant chemoradiotherapy for local and systemic control in patients with locally advanced rectal cancer
por: Klautke, G, et al.
Publicado: (2006)

Reply
por: Derespina, Kim R., et al.
Publicado: (2021)

Reply: Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib
por: Mickisch, G H J, et al.
Publicado: (2010)

Reply
por: Algarroba, Gabriela N., et al.
Publicado: (2020)

Reply: Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer
por: Ohwada, S, et al.
Publicado: (2004)

REPLY
por: Chandrasekaran, R.
Publicado: (1999)

Reply
por: Mahendru, R.K.
Publicado: (1990)

Reply
por: Alvarez, Ronald D., et al.
Publicado: (2021)

Reply
por: Kaushik, Shubhi, et al.
Publicado: (2020)

Authors’ reply
por: Bharathi, M Jayahar, et al.
Publicado: (2012)

In Reply
por: Brennen, W. Nathaniel, et al.
Publicado: (2019)

Author's reply
por: Vimalavathini, R., et al.
Publicado: (2010)

Authors' reply
por: Kalikar, M.V., et al.
Publicado: (2010)

Reply
por: Lokken, Erica M., et al.
Publicado: (2020)

In Reply: Overall Survival of Resectable Metastatic Colon Cancer Treated With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy in Non-academic Program
por: Hao, Zhonglin, et al.
Publicado: (2023)

Reply()
por: Barrios-López, J.M., et al.
Publicado: (2021)

Reply
por: Cavuoto, Kara M.
Publicado: (2021)

Authors’ reply
por: Tanna, Ila, et al.
Publicado: (2011)

Authors’ reply
por: Arora, Vipul, et al.
Publicado: (2010)

Reply
por: Yonker, Lael M., et al.
Publicado: (2021)

Reply
por: Yonker, Lael M., et al.
Publicado: (2021)

Authors’ reply
por: Das, Pranab, et al.
Publicado: (2010)

In Reply
por: Goldberg, Richard M., et al.
Publicado: (2017)

Reply
por: Pinto-Sanchez, M. Ines, et al.
Publicado: (2021)

Treatment failure patterns of adjuvant gefitinib therapy and minimal residual disease detection in resected EGFR-mutant non-small cell lung cancer: author’s reply
por: Xu, Song-Tao, et al.
Publicado: (2020)

Authors' reply
por: Arora, Vipul L, et al.
Publicado: (2010)

Reply
por: Forrer, F., et al.
Publicado: (2007)

Survival in renal cell carcinoma: a randomized evaluation of tamoxifen vs interleukin-2, α-interferon (leucocytic) and tamoxifen – reply
Publicado: (2000)

Reply
por: Villaverde, Serena, et al.
Publicado: (2021)

Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
por: Khan, O A, et al.
Publicado: (2012)

Authors' reply
por: Jasuja, S., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_msld2e4ktmc92mu0i7pbdc8ml8